什么时候是告别抗凝的时候？

IF 3.8 2区医学 Q1 HEMATOLOGY

British Journal of Haematology Pub Date : 2025-08-22 DOI:10.1111/bjh.70114

Julia Czuprynska, Roopen Arya

{"title":"什么时候是告别抗凝的时候？","authors":"Julia Czuprynska, Roopen Arya","doi":"10.1111/bjh.70114","DOIUrl":null,"url":null,"abstract":"Decisions about antithrombotic therapy in cancer patients at the end of life can be challenging. This cohort study examined prescribing behaviour and outcomes relating to antithrombotic therapy in this patient group, finding that deprescribing was uncommon. Greater awareness of this neglected but high-risk aspect of patient care is required along with interventions to enable shared decision-making in this setting. Commentary on: Aldridge et al. Antithrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: a cohort study using population-linked routinely collected data. Br J Haematol 2025 (Online ahead of print). https://doi.org/10.1111/bjh.70032.","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"When is it time to bid farewell to anticoagulation?\",\"authors\":\"Julia Czuprynska, Roopen Arya\",\"doi\":\"10.1111/bjh.70114\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Decisions about antithrombotic therapy in cancer patients at the end of life can be challenging. This cohort study examined prescribing behaviour and outcomes relating to antithrombotic therapy in this patient group, finding that deprescribing was uncommon. Greater awareness of this neglected but high-risk aspect of patient care is required along with interventions to enable shared decision-making in this setting. Commentary on: Aldridge et al. Antithrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: a cohort study using population-linked routinely collected data. Br J Haematol 2025 (Online ahead of print). https://doi.org/10.1111/bjh.70032.\",\"PeriodicalId\":135,\"journal\":{\"name\":\"British Journal of Haematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Haematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bjh.70114\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bjh.70114","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

癌症患者在生命末期进行抗血栓治疗的决定是具有挑战性的。这项队列研究检查了该患者组中与抗血栓治疗相关的处方行为和结果，发现开处方并不常见。需要提高对这一被忽视但高风险的患者护理方面的认识，并采取干预措施，以便在这种情况下共同决策。评论：Aldridge等人。癌症患者生命末期的抗血栓治疗及相关临床结果：一项使用人群相关常规收集数据的队列研究[J]中国生物医学工程学报，2025（在线预印）。https://doi.org/10.1111/bjh.70032。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

When is it time to bid farewell to anticoagulation?

Decisions about antithrombotic therapy in cancer patients at the end of life can be challenging. This cohort study examined prescribing behaviour and outcomes relating to antithrombotic therapy in this patient group, finding that deprescribing was uncommon. Greater awareness of this neglected but high-risk aspect of patient care is required along with interventions to enable shared decision-making in this setting. Commentary on: Aldridge et al. Antithrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: a cohort study using population-linked routinely collected data. Br J Haematol 2025 (Online ahead of print). https://doi.org/10.1111/bjh.70032.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

British Journal of Haematology 医学-血液学

CiteScore

8.60

自引率

4.60%

发文量

565

审稿时长

1 months

期刊介绍： The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.